Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4284372
[patent_doc_number] => RE037447
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Modified Kluyveromyces yeasts, their preparation and use'
[patent_app_type] => 2
[patent_app_number] => 9/640305
[patent_app_country] => US
[patent_app_date] => 2000-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 15876
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/037/RE037447.pdf
[firstpage_image] =>[orig_patent_app_number] => 640305
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/640305 | Modified Kluyveromyces yeasts, their preparation and use | Aug 15, 2000 | Issued |
Array
(
[id] => 1331742
[patent_doc_number] => 06596533
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Mutant having uracil phosphoribosyl transferase activity'
[patent_app_type] => B1
[patent_app_number] => 09/446084
[patent_app_country] => US
[patent_app_date] => 2000-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14620
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596533.pdf
[firstpage_image] =>[orig_patent_app_number] => 09446084
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446084 | Mutant having uracil phosphoribosyl transferase activity | Aug 13, 2000 | Issued |
09/632879 | Growth differentiation factor promoter and uses therefor | Aug 3, 2000 | Abandoned |
09/242951 | SpoOJ2 of staphylococcus aureus | Jul 27, 2000 | Abandoned |
Array
(
[id] => 671995
[patent_doc_number] => 07091003
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-15
[patent_title] => 'Polypeptides having phospholipase B activity and nucleic acids encoding same'
[patent_app_type] => utility
[patent_app_number] => 09/615571
[patent_app_country] => US
[patent_app_date] => 2000-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19506
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/091/07091003.pdf
[firstpage_image] =>[orig_patent_app_number] => 09615571
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/615571 | Polypeptides having phospholipase B activity and nucleic acids encoding same | Jul 12, 2000 | Issued |
Array
(
[id] => 1282713
[patent_doc_number] => 06638502
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-28
[patent_title] => 'Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors'
[patent_app_type] => B1
[patent_app_number] => 09/403736
[patent_app_country] => US
[patent_app_date] => 2000-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19994
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/638/06638502.pdf
[firstpage_image] =>[orig_patent_app_number] => 09403736
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403736 | Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors | Jun 28, 2000 | Issued |
Array
(
[id] => 7645762
[patent_doc_number] => 06472207
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Method for producing tagged genes, transcripts, and proteins'
[patent_app_type] => B1
[patent_app_number] => 09/604037
[patent_app_country] => US
[patent_app_date] => 2000-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 5130
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472207.pdf
[firstpage_image] =>[orig_patent_app_number] => 09604037
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/604037 | Method for producing tagged genes, transcripts, and proteins | Jun 26, 2000 | Issued |
Array
(
[id] => 1380778
[patent_doc_number] => 06551825
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-22
[patent_title] => 'PiggyBac transposon-based genetic transformation system for insects'
[patent_app_type] => B1
[patent_app_number] => 09/598421
[patent_app_country] => US
[patent_app_date] => 2000-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 63
[patent_no_of_words] => 18583
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/551/06551825.pdf
[firstpage_image] =>[orig_patent_app_number] => 09598421
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/598421 | PiggyBac transposon-based genetic transformation system for insects | Jun 18, 2000 | Issued |
Array
(
[id] => 1516310
[patent_doc_number] => 06500432
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-31
[patent_title] => 'Method to enhance an immune response of nucleic acid vaccination'
[patent_app_type] => B1
[patent_app_number] => 09/581368
[patent_app_country] => US
[patent_app_date] => 2000-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8666
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500432.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581368
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581368 | Method to enhance an immune response of nucleic acid vaccination | Jun 11, 2000 | Issued |
09/509937 | SYNTHETIC GENES WITH IMMUNOMODULATORY EFFECTS | Jun 8, 2000 | Abandoned |
Array
(
[id] => 512004
[patent_doc_number] => 07196244
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-03-27
[patent_title] => 'Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans'
[patent_app_type] => utility
[patent_app_number] => 09/980644
[patent_app_country] => US
[patent_app_date] => 2000-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 13330
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/196/07196244.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980644
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980644 | Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans | May 31, 2000 | Issued |
Array
(
[id] => 1391838
[patent_doc_number] => 06537540
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-25
[patent_title] => 'Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders'
[patent_app_type] => B1
[patent_app_number] => 09/579845
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 29
[patent_no_of_words] => 28897
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/537/06537540.pdf
[firstpage_image] =>[orig_patent_app_number] => 09579845
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/579845 | Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders | May 25, 2000 | Issued |
Array
(
[id] => 6473505
[patent_doc_number] => 20020151509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Adeno-associated viral vector-mediated delivery of DNA to cells of the liver'
[patent_app_type] => new
[patent_app_number] => 09/576858
[patent_app_country] => US
[patent_app_date] => 2000-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13225
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151509.pdf
[firstpage_image] =>[orig_patent_app_number] => 09576858
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/576858 | Adeno-associated viral vector-mediated delivery of DNA to cells of the liver | May 21, 2000 | Issued |
09/576081 | Use of chimeric mutational vectors to change endogenous sequences in solid tissues | May 19, 2000 | Abandoned |
Array
(
[id] => 1091736
[patent_doc_number] => 06824771
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-30
[patent_title] => 'Infectivity-enhanced conditionally-replicative adenovirus and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/569789
[patent_app_country] => US
[patent_app_date] => 2000-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 34
[patent_no_of_words] => 18431
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/824/06824771.pdf
[firstpage_image] =>[orig_patent_app_number] => 09569789
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/569789 | Infectivity-enhanced conditionally-replicative adenovirus and uses thereof | May 11, 2000 | Issued |
Array
(
[id] => 1073781
[patent_doc_number] => 06838446
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-04
[patent_title] => 'Vector for expression of GPI-enzyme hybrid'
[patent_app_type] => utility
[patent_app_number] => 09/959007
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 16671
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838446.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959007
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959007 | Vector for expression of GPI-enzyme hybrid | Apr 27, 2000 | Issued |
Array
(
[id] => 658316
[patent_doc_number] => 07105494
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-12
[patent_title] => 'Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies'
[patent_app_type] => utility
[patent_app_number] => 09/561524
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10624
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09561524
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/561524 | Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies | Apr 27, 2000 | Issued |
Array
(
[id] => 1516267
[patent_doc_number] => 06500419
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-31
[patent_title] => 'Method for introducing and expressing RNA in animal cells'
[patent_app_type] => B1
[patent_app_number] => 09/545153
[patent_app_country] => US
[patent_app_date] => 2000-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26414
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500419.pdf
[firstpage_image] =>[orig_patent_app_number] => 09545153
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/545153 | Method for introducing and expressing RNA in animal cells | Apr 6, 2000 | Issued |
Array
(
[id] => 1514351
[patent_doc_number] => 06420161
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'dnaB from Staphylococcus aureus'
[patent_app_type] => B1
[patent_app_number] => 09/543141
[patent_app_country] => US
[patent_app_date] => 2000-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15897
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420161.pdf
[firstpage_image] =>[orig_patent_app_number] => 09543141
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/543141 | dnaB from Staphylococcus aureus | Apr 4, 2000 | Issued |
09/526947 | Enhanced Gamma-carboxylation of recombinant vitamin K-dependent clotting factors | Mar 15, 2000 | Abandoned |